Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | GLA | P06280 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1942331 | 0.87 | MAOA (0.59) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL9536657 | 0.81 | MAOA (0.45) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL5735188 | 0.80 | MAOA (0.44) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL2158474 | 0.80 | ALDH1A1 (0.43) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL6006642 | 0.80 | ALDH1A1 (0.43) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL9450945 | 0.79 | MAOA (0.40) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL787917 | 0.78 | MAOA (0.44) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL15427854 | 0.78 | MAOA (0.42) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL25165121 | 0.77 | ESR1 (0.43) | MAOAALDH1A1KDM4EGLAHPGD | |
| SCHEMBL549009 | 0.76 | LMNA (0.57) | MAOAALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113214105-A | 150-cavity targeted oseltamivir derivative and preparation method and application thereof | 山东大学 | 2021-08-06 | — | — | CN | claimed |
| EP-0274574-A2 | Composition and method for repelling insects | S.C. JOHNSON & SON, INC. (US) | 1988-07-20 | — | — | EP | claimed |
| JP-2248424-A | — | — | None | — | — | JP | disclosed |
| US-12091600-B2 | Compound and color conversion film comprising same, backlight unit, and display device | LG CHEM, LTD. (KR) | 2024-09-17 | — | — | US | disclosed |
| CN-112041322-B9 | Compound, color conversion film, backlight unit, and display device including the same | 株式会社LG化学 | 2023-10-17 | — | — | CN | disclosed |
| CN-112041322-B | Compound, color conversion film, backlight unit, and display device including the same | 株式会社LG化学 | 2023-09-08 | — | — | CN | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| US-11503831-B2 | Arthropoda repellent composition | SANDERSTROTHMANN GMBH (DE) | 2022-11-22 | — | — | US | disclosed |
| CN-113214105-B | 150-cavity targeted oseltamivir derivative and preparation method and application thereof | 山东大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-113214105-A | 150-cavity targeted oseltamivir derivative and preparation method and application thereof | 山东大学 | 2021-08-06 | — | — | CN | disclosed |
| US-20210222060-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2021-07-22 | — | — | US | disclosed |
| US-5049581-A | Dibenzofurans having anti-tumor activity | BURROUGHS WELLCOME CO. (US) | 1991-09-17 | — | — | US | disclosed |
| US-5017600-A | Antitumor | BURROUGHS WELLCOME CO. (US) | 1991-05-21 | — | — | US | disclosed |
| US-5008286-A | Antitumor agents | BURROUGHS WELLCOME CO. (US) | 1991-04-16 | — | — | US | disclosed |
| US-4970227-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4965285-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1990-10-23 | — | — | US | disclosed |
| JP-H02248424-A | AROMATIC POLYMERS | IMPERIAL CHEM IND PLC <ICI> | 1990-10-04 | — | — | JP | disclosed |
| US-4866070-A | ANTITUMOR AGENT | BURROUGHS WELLCOME CO. (US) | 1989-09-12 | — | — | US | disclosed |
| US-4764618-A | TRYPSIN INHIBITOR, PANCREATITIS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1988-08-16 | — | — | US | disclosed |
| EP-0183439-A2 | Polycyclic compounds, their preparation and use and formulations containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | MAOA 934/4885ALDH1A1 2839/4885KDM4E 3740/4885 |
| US-20210222060-A1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | CYP1B1, ALDH1A2, ALDH1A1 | MAOA 96/4885ALDH1A1 3/4885KDM4E 1692/4885 |
| US-12091600-B2 | Compound and color conversion film comprising same, backlight unit, and display device | CYP1B1, ALDH1A2, ALDH1A1 | MAOA 96/4885ALDH1A1 3/4885KDM4E 1692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.